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Kaohsiung Medical University, Kaohsiung, TaiwanAbstractThe pathogenesis of community-associated methicillin-resistant
Staphylococcus aureus (CA-MRSA) pneumonia in inﬂuenza-infected
elderly individuals has not yet been elucidated in detail. In the
present study, a 92-year-old man infected with inﬂuenza developed
CA-MRSA pneumonia. His CA-MRSA was an emerging type,
originated in ST121/agr4 S. aureus, with diversities of
Panton–Valentine leucocidin (PVL)−/spat5110/SCCmecV+ versus
PVL+/spat159(etc.)/SCCmec−, but with common virulence potentials
of strong adhesin and cytolytic activities. Resistance to erythromycin/
clindamycin (inducible-type) and gentamicin was detected.
Pneumonia improved with the administration of levoﬂoxacin, but
with the subsequent development of fatal aspiration pneumonia.
Hence, characteristic CA-MRSA with strong adhesin and cytolytic
activities triggered inﬂuenza-related sequential complications.
© 2016 Published by Elsevier Ltd on behalf of European Society of
Clinical Microbiology and Infectious Diseases.
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T.-W. Wan and Y. Tomita contributed equally to this work.IntroductionStaphylococcus aureus is a major human pathogen that causes
skin and soft-tissue infections, life-threatening infections such as
pneumonia and sepsis, and toxinoses including toxic shock
syndrome. Methicillin-susceptible S. aureus (MSSA) has evolved
as methicillin-resistant S. aureus (MRSA) through the acquisition
of staphylococcal cassette chromosome mec (SCCmec) [1–3].
Two types of MRSA have been identiﬁed [1]: traditional
MRSA, which emerged in hospitals in 1961 and is now classiﬁed
as healthcare-associated MRSA (HA-MRSA) with global exam-
ples of ST239/SCCmecIII and ST5/SCCmecII [4,5], and
community-associated MRSA (CA-MRSA), which emerged in
the community in 1997–1999 with global examples of ST8/
SCCmecIV (USA300), ST30/SCCmecIV, ST80/SCCmecIV and
ST59/SCCmecV [3,5,6,7]. Hence, globally disseminated ST30/
agr3 (but not ST121/agr4) MSSA actually evolved as global CA-
MRSA [8].
CA-MRSA possesses distinct virulence factors from those of
HA-MRSA, for example, it more strongly expresses cytolytic
peptides, such as phenol-soluble modulins (PSMs) [6,9,10], and
frequently produces Panton–Valentine leucocidin (PVL)
[6,7,10,11]. Successful CA-MRSA also has unique virulence
factors, as typically shown with USA300 [3,6,10].
The elderly are susceptible to S. aureus community-acquired
pneumonia (CAP) that requires hospitalization [12], and this
may be due to a functionally dysregulated host immune system
[13]. Moreover, inﬂuenza-infected elderly individuals are at risk
of bacterial pneumonia; inﬂuenza impairs host immunological
mechanisms [14] and promotes co-infections or sequential in-
fections with S. aureus or CA-MRSA [14–16]. Although PVL is
not necessary [16], the pathogenesis of inﬂuenza-related CA-
MRSA CAP remains unclear.
We herein isolated ST121/agr4 CA-MRSA from inﬂuenza-
related MRSA CAP for the ﬁrst time. We then attempted to
elucidate the molecular features of CA-MRSA and gain novelNew Microbe and New Infect 2016; 13: 17–21
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triggered sequential complications.CaseA 92-year-old man was diagnosed with inﬂuenza A using an
inﬂuenza rapid diagnostic (antigen detection) test on 25 January
2013, and was treated with oseltamivir phosphate (150 mg per
day); however, no improvements were noted in his symptoms.
He was admitted to a hospital on 27 January 2013 (day 1) with
fever and progressive dyspnoea. He had a previous history of
cerebral infarction, but did not need regular home visits by
healthcare workers and did not have a urinary catheter. He did
not have established risk factors for HA-MRSA infections such
as a history of hospitalization, surgery, haemodialysis, the
presence of a permanent indwelling catheter or percutaneous
medical device, or residence in a long-term care facility in the
past year [1]. He also had no previous MRSA infections or
history of recent antibiotic use. On admission, his white blood
cell count and C-reactive protein level were 20,200/μL and
33.3 mg/dL, respectively. Chest radiography revealed bilateral
pulmonary inﬁltrates (Fig. 1): an inﬁltrative shadow in the right
lung (arrow 1) and consolidation with air bronchograms on the
lateral side of the left middle lung ﬁeld (arrow 2). The pattern of
the chest radiography ﬁndings, a peripherally distributedFIG. 1. Chest X-ray of the patient on admission day 1. A chest
radiograph shows bilateral pulmonary inﬁltrates. Arrow 1 indicates an
inﬁltrative shadow overlapping the second arch in the middle to lower
ﬁeld of the right lung, while arrow 2 indicates consolidation with air
bronchograms on the lateral side of the left middle lung ﬁeld.
© 2016 Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Inf
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MRSA pneumonia than with MSSA pneumonia [17]. Respiratory
failure (SpO2, 76%) was noted. Chemotherapy was initiated
with a drip infusion of piperacillin (2 g every 12 h). On day 2,
sputum was examined, MRSA was detected in cultures (at 107
CFU/mL), and the presence of intracellular MRSA in poly-
morphs was conﬁrmed microscopically; no other pathogens
were detected. On day 5, oral levoﬂoxacin (500 mg every 24 h)
was initiated based on the results of drug-susceptibility testing
for MRSA (see Supplementary material, Table S1). His respi-
ratory status rapidly improved, and his white blood cell count
and C-reactive protein level also improved (4,500/μL and
1.7 mg/dL, respectively) on day 14 (7 February 2013). Hospi-
talization was continued due to severe anorexia; however, he
developed aspiration pneumonia on 11 April and died on 19
April. This case of MRSA, epidemiologically classiﬁed as CA-
MRSA [1], was named KT1.Characterization of microbesThe molecular typing of MRSA, such as sequence type (ST),
clonal complex (CC), spa, agr, SCCmec [2], and Coagulase
(Coa), was performed as described previously [18]. Forty-nine
virulence genes were analysed by PCR [18]: three leucocidin
genes (lukPVSF, lukE-lukD and lukM), ﬁve haemolysin genes (hla,
hlb, hlg, hlg-v and hld), the peptide cytolysin, PSMα (psmα), 19
staphylococcal superantigen genes, named enterotoxin (SE) or
enterotoxin-like (SEl) (tst, sea-e, seg-j, selk-r and selu), staphy-
lococcal exotoxin (set) genes, a staphylococcal superantigen-
like gene cluster (ssl), 3 exfoliative toxin (ET) genes (eta/b and
etd), the epidermal cell differentiation inhibitor gene (edin), 14
adhesin genes (icaA/D, eno, ﬁb, fnbA/B, ebpS, clfA/B, sdrC-E, cna
and bbp), and the arginine catabolic mobile element-arcA gene.
MRSA plasmids were analysed as described previously [18].
Bacterial susceptibility testing was performed using the agar
dilution method with Mueller–Hinton agar [18]. The mRNA
expression level of the PSMα gene (psmα) was examined using
an RT-PCR assay [18]. Data were analysed statistically using the
Student’s t-test. The level of signiﬁcance was deﬁned as p <0.05.
KT1 exhibited ST121/agr4 and was positive for the entero-
toxin gene cluster (egc) with seg, sei, selm, seln, selo and selu [19]
(Fig. 2a), similar to global ST121/agr4 MSSA [8]. However, KT1
was negative for PVL, and its spa type (spa1493(t5110)) was
divergent from global ST121/agr4 MSSA [8,20].
KT1 carried SCCmecV, a characteristic SCCmec of CA-MRSA
[2,3,5], and oxacillin and imipenem resistance levels were low,
which is consistent with CA-MRSA [5,18]. KT1 carried the
characteristic combination of the adhesin genes, cna (for collagen
binding) and bbp (for bone sialoprotein binding). Moreover, theectious Diseases, NMNI, 13, 17–21
nses/by-nc-nd/4.0/).
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FIG. 2. Molecular characteristics (a) and mRNA expression levels of the cytolytic peptide gene (psmα) (b) of community-associated methicillin-
resistant Staphylococcus aureus (CA-MRSA) strain KT1. In (a), superscript letters indicate the following: athe split hlb gene due to the insertion of phage
Sa3; beight adhesin genes are common among S. aureus; cthe 2,473-bp plasmid pWKT1 (GenBank Accession number, LC086373) carried ermC with the
leader peptide sequence, responsible for inducible (ind) resistance to clindamycin; pWKT1 was 100% homologous to the pKH19 of MRSA spat1081
(GenBank Accession number, EU350089) and 99% homologous to the pOC160-1 of ST8 CA-MRSA from Russia (GenBank Accession number,
AB982226); and daacA-aphD encoded for resistance (r) to gentamicin. (b) Strains KT1 and USA300-0114 are CA-MRSA, and strains N315 and Mu50
are healthcare-associated (HA-) MRSA. The mRNA expression levels of the phenol-soluble modulin α (PSMα) gene (psmα), normalized to 16S rRNA
expression levels, were 0.64 ± 0.13, 0.05 ± 0.02, 0.07 ± 0.02 and 0.63 ± 0.13 for strains KT1, N315, Mu50 and USA300-0114, respectively; the psmα
expression level of KT1 (no. 1) was similar to that of USA300-0114 (no. 2), and was signiﬁcantly higher than that of HA-MRSA (p <0.01).
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that of HA-MRSA (p <0.01), similar to CA-MRSA USA300
(Fig. 2b). Possible ancestral ST121/agr4 MSSA strains also
exhibited the same virulence characteristics (see Supplementary
material, Fig. S1); those ST121/agr4 MSSA strains (n=14) were
PVL+, Coa V, cna+, bbp+, and egc+, and harbored stronger PSMα
activities than other MSSA strains [21].
KT1 carried an ermC plasmid (pWKT1), specifying for induc-
ible clindamycin resistance, and the aacA-aphD gene encoding for
gentamicin resistance (Fig. 2a; see Supplementary material,
Table S1). KT1 was susceptible to generally recommended anti-
MRSA agents (see Supplementary material, Table S1).DiscussionST121/agr4 MRSA (KT1) met the CDC criteria for CA-MRSA
[1]. Moreover, KT1 was bacteriologically consistent with CA-
MRSA, based on the SCCmecV carriage [2,3,5], SCCmec© 2016 Published by Elsevier Ltd on behal
This is an open access artic(mecA) -mediated low level of resistance to oxacillin and imi-
penem [2,5,18], weaker multidrug resistance [5], and strong
cytolytic activity [6,9,10]. Although elderly MRSA pneumonia in
Japan is mostly from ST5/SCCmecII HA-MRSA and, hence,
resistant to ﬂuoroquinone [5], MRSA CAP in the present study
was a rare ﬂuoroquinone-susceptible case. KT1 exhibited
gentamicin and inducible-clindamycin resistance, similar to CA-
MRSA in Japan.
We herein described the ﬁrst case of MRSA CAP from
ST121/agr4 CA-MRSA (KT1), originated from PVL+ ST121/agr4
MSSA (including spa type t159), which was globally dissemi-
nated in association with skin and soft-tissue infections and
necrotizing pneumonia [8,20]. A unique feature of KT1 over
other ST121/agr4 MSSA was PVL–, spat5110 and SCCmecV+.
Inﬂuenza impairs host immunological mechanisms [14],
promoting the development of CA-MRSA pneumonia [14,16].
The present case also had inﬂuenza-related CA-MRSA CAP,
with chest radiography ﬁndings showing MRSA pneumonia [17],
and was successfully treated with levoﬂoxacin.f of European Society of Clinical Microbiology and Infectious Diseases, NMNI, 13, 17–21
le under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
20 New Microbes and New Infections, Volume 13 Number C, September 2016 NMNIWe strongly speculate that CA-MRSA associated with CAP
harbours unique adhesin and toxic activities that act against the
inﬂuenza-impaired respiratory tract mucosa. The present case
was PVL-independent, which is consistent with previous ﬁnd-
ings [16]. KT1 (the ST121/agr4 lineage, irrespective of PVL+ or
PVL− and MRSA or MSSA) harboured strong adhesin and toxic
activities, as characterized by collagen and bone-sialoprotein
adhesins, six egc-encoded superantigens, and the strong
expression of PSMα. Collagen adhesin is considered to be
associated with CAP, possibly through MRSA adherence to
damaged tissues, for example, due to viral infection [22].
Globally disseminated ST30/agr3/SCCmecIV CA-MRSA, which
has been associated with severe MRSA CAP, also harboured
the same adhesin and toxic activities [23,24].
The present CA-MRSA CAP case, possibly in combination
with his previous history of cerebral infarction, developed a
decline in the activities of daily living. Pneumonia events have
been associated with the loss of physical functioning [25]. In
addition, in our patient, CA-MRSA CAP may also have damaged
deglutition functions, possibly due to the strong adhesin and
cytolytic activities of ST121/agr4 CA-MRSA, resulting in aspi-
ration pneumonia.
ST121 CA-MRSA has been isolated from skin and soft-tissue
infections, such as impetigo; however, its genetic characteristics
remain unknown [26,27]; KT1 was negative for impetigo-
associated ETs. The ST121/agr4 lineage may be evolving, in
two ways, as PVL+, ET+ impetigo-associated CA-MRSA and as
PVL– (or PVL+) CAP-associated CA-MRSA.
In conclusion, we isolated ST121/agr4 CA-MRSA (KT1) from
inﬂuenza-related CA-MRSA CAP for the ﬁrst time. KT1 origi-
nated from globally disseminated PVL+ ST121/agr4 MSSA (with
strong adhesin and cytolytic activities), with the unique KT10
feature of PVL–/spat5110/SCCmecV+. Pneumonia improved
with levoﬂoxacin administration, but with the subsequent
development of fatal aspiration pneumonia. Hence, professional
ST121/agr4 CA-MRSA, with high adhesin and cytolytic activities,
triggered inﬂuenza-related sequential complications (CAP and
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